Literature DB >> 31679617

Perioperative Atrial Fibrillation in Noncardiac Surgeries for Malignancies and One-Year Recurrence.

Satoshi Higuchi1, Yusuke Kabeya2, Kenichi Matsushita3, Nobuaki Arai4, Keisei Tachibana4, Ryota Tanaka4, Riken Kawachi5, Hidefumi Takei6, Yutaka Suzuki7, Masaharu Kogure7, Yorihisa Imanishi8, Kiyoshi Moriyama9, Masanori Sugiyama7, Tomoko Yorozu9, Koichiro Saito10, Nobutsugu Abe7, Haruhiko Kondo4, Hideaki Yoshino3.   

Abstract

BACKGROUND: Perioperative atrial fibrillation (POAF) in noncardiac surgeries is common. However, it is unclear whether such atrial fibrillation (AF) recurs in the long term.
METHODS: This study was a prospective, single-center, observational study that included patients who underwent noncardiac surgeries for malignancies. Patients were followed up for 1 year to evaluate the incidence of AF, ischemic stroke, and mortality. An event-triggered recorder was used in patients with POAF. The incidences were compared according to the presence of POAF.
RESULTS: Of 752 consecutive patients, 77 (10.2%) developed POAF and wore an event recorder for 19 (12-30) days. AF and ischemic stroke at 1 year were observed in 24 patients (31.1%) and 2 patients (2.6%) with POAF and 4 patients (0.6%) and 3 patients (0.4%) without POAF, respectively. Of the 24 patients with POAF and AF recurrence, 22 (92%) were asymptomatic. Anticoagulation was prescribed in 67 patients (87%) with POAF. Multivariate Cox regression analysis demonstrated that a higher AF recurrence rate in patients with POAF was associated with hypertension (hazard ratio, 2.79; 95% confidence interval, 1.06-7.38) and serum creatinine level (hazard ratio for 20 μmol/L increase, 2.32; 95% confidence interval, 1.16-4.62).
CONCLUSIONS: AF recurs in approximately 30% of patients with POAF with malignancy in the subsequent year; most recurrences are asymptomatic.
Copyright © 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31679617     DOI: 10.1016/j.cjca.2019.07.008

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  5 in total

1.  A randomized controlled trial of brain and heart health manager-led mHealth secondary stroke prevention.

Authors:  Shasha Wang; Ying Li; Jishu Tian; Xiaoqiong Peng; Ling Yi; Cuiping Du; Changmei Feng; Chunmei Liu; Rong Deng; Xianju Liang
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

2.  Amiodarone with or without N-Acetylcysteine for the Prevention of Atrial Fibrillation after Thoracic Surgery: A Double-blind, Randomized Trial.

Authors:  David Amar; Hao Zhang; Mina K Chung; Kay See Tan; Dawn Desiderio; Bernard J Park; Alessia Pedoto; Nancy Roistacher; James M Isbell; Daniela Molena; Ginger L Milne; Bryan F Meyers; Gregory W Fischer; Valerie W Rusch; David R Jones
Journal:  Anesthesiology       Date:  2022-06-01       Impact factor: 7.892

3.  Self-monitoring for recurrence of secondary atrial fibrillation following non-cardiac surgery or acute illness: A pilot study.

Authors:  Nicole Lowres; Graham S Hillis; Marc A Gladman; Mark Kol; Jim Rogers; Vincent Chow; Ferris Touma; Cara Barnes; Joanne Auston; Ben Freedman
Journal:  Int J Cardiol Heart Vasc       Date:  2020-06-29

Review 4.  Incidence, Management, Prevention and Outcome of Post-Operative Atrial Fibrillation in Thoracic Surgical Oncology.

Authors:  Iacopo Fabiani; Alessandro Colombo; Giulia Bacchiani; Carlo Maria Cipolla; Daniela Maria Cardinale
Journal:  J Clin Med       Date:  2019-12-23       Impact factor: 4.241

Review 5.  Association Between Perioperative Atrial Fibrillation and Long-term Risks of Stroke and Death in Noncardiac Surgery: Systematic Review and Meta-analysis.

Authors:  Jessica T Huynh; Jeff S Healey; Kevin J Um; Maria E Vadakken; Anand S Rai; David Conen; Pascal Meyre; Jawad H Butt; Hooman Kamel; Seleman J Reza; Stephanie T Nguyen; Zardasht Oqab; P J Devereaux; Kumar Balasubramanian; Alexander P Benz; Emilie P Belley-Cote; William F McIntyre
Journal:  CJC Open       Date:  2021-01-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.